Investor profile
Braavos Investment Advisers
VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Braavos Investment Advisers is a specialist venture capital firm investing in companies founded on scientific breakthroughs. The firm is an early- to growth-stage investor with a particular focus on companies linked to the University of Oxford — the world's epicentre of research excellence — and partners with inspired founders building enterprises on the premise of scientific and technological breakthroughs. Braavos manages over $500M in AUM and targets sectors including biotechnology, life sciences, quantum computing, AI-driven drug discovery, climate technology, cybersecurity, and deep tech. The firm provides board-level involvement, capital, extensive networks, and strategic talent to help portfolio companies navigate long development timelines, technical risks, and the path from ground-breaking research to global markets.
Notable quotes
“Passion and mindset are the scarcest assets.”
“I broke all my cardinal rules in investing. Where you own most of the equity, you end up owning most of the problems.”
Team
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Wild Bioscience (Wild Bio) | Series A | $60m | 2025-10-10 |
| OXCCU | Series B | $26m | 2023-06-07 |
| Salience Labs | Series A | $30m | 2025-02-08 |
| Oxford Ionics | Series A | $38m | 2023-01-09 |
| PQShield | Series B | $37m | 2024-06-20 |
| Osler Diagnostics | Series C | $85m | 2022-11-07 |
| First Light Fusion | Series C | $45m | 2022-02-14 |
| CHARM Therapeutics | Series A | $50m | 2022-06-09 |
| SpyBiotech | Series A | $33m | 2021-02-10 |
| Living Optics | Seed | — | 2022-08-11 |
Frequent co-investors
Fit check
Is Braavos Investment Advisers a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit